Investigation of prognostic markers in endemic Burkitt lymphoma

Peixun Zhou, Alexander Newman, Susan Van Noorden, Kondwani Banda, George Chagaluka, Irvin Lampert, Amy Erhorn, Chris Bacon, Simon Bailey, Elizabeth Molyneux, Vikki Rand

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

Unlike many other childhood cancers, genomic abnor-
malities are not used in the clinical management of paediatric Bur-
kitt lymphoma (BL) and few prognostic biomarkers have been
identified. In sporadic BL gain of chromosome 7 and deletion of 13q
are the only abnormalities that have been associated with an adverse
prognosis in the context of a clinical trial. Gains of 13q have also
been reported, including gain of the miR17HG locus, but the prog-
nostic value in endemic BL is unknown
Original languageEnglish
Pages (from-to)2-2
JournalBritish Journal of Haematology
Volume171
Issue numberSuppl 1
DOIs
Publication statusPublished - 4 Oct 2015
EventFifth International Symposium on Childhood Adolescent and Young Adult Non-Hodgkin Lymphoma - Varase, Italy
Duration: 22 Oct 201524 Oct 2015
https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.13753

Fingerprint Dive into the research topics of 'Investigation of prognostic markers in endemic Burkitt lymphoma'. Together they form a unique fingerprint.

Cite this